logo
#

Latest news with #Quest

Next-Gen Breakthroughs Transform Influenza Diagnostics
Next-Gen Breakthroughs Transform Influenza Diagnostics

Time Business News

time4 hours ago

  • Business
  • Time Business News

Next-Gen Breakthroughs Transform Influenza Diagnostics

Influenza diagnostics refers to methods and devices that are used to detect influenza virus infections in individuals, including rapid antigen tests, molecular assays (such as RT-PCR), and immunoassays. The market for influenza diagnostics is increasing due to increasing global awareness about infectious diseases, increasing incidence of influenza and increasing outbreaks, increasing demand for rapid and accurate testing, increasing demand for progress in clinical technologies and further emphasis on the identity of initial diseases and the identity of early diseases by governments and healthcare organizations. Key Growth Drivers and Opportunities Global Awareness about Infectious Diseases: Global awareness about infectious diseases increases the demand for increasing, accurate, accurate and comprehensive testing. Recent experiences with epidemic such as public health campaigns, media coverage, and Covid-19 have increased the importance of the general population of viral transmission and timely diagnosis. As a result, the healthcare provider and the government are prioritizing investment in clinical infrastructure, rapid testing development and monitoring systems to prevent large -scale outbreaks. This awareness leads to maximum adoption of influenza diagnostic tools in hospitals, clinics, airports and even home settings, which promotes continuous market growth. Challenges Influenza diagnostics faces the high cost of advanced testing technologies in the market, low income and clinical equipment limited to clinical equipment in rural areas and the limits of variability in test accuracy-especially with antigen tests that may be false negative. Additionally, the seasonal nature of influenza may demand ups and downs, affecting continuous revenue creation and investment. Regulatory obstacles and skilled personnel need to be widely adopted to adopt molecular diagnosis. Innovation and Expansion Quest Diagnostics Gets CDC Contracts to Create Oropouche Virus and H5 Avian Flu Tests In October 2024, leading diagnostic information services provider Quest Diagnostics announced that the U.S. Centers for Disease Control and Prevention (CDC) has awarded it multiple contracts to support testing and ongoing laboratory readiness for two newly discovered infectious diseases in the Americas. By guaranteeing that a national commercial laboratory provider may promptly augment public health laboratories in the case of an infectious disease epidemic in humans, the agreements will enhance the country's readiness for avian influenza and Oropouche viruses. The FDA Approves the First Over-the-Counter Flu and COVID-19 Test at Home In February 2023, the first over-the-counter (OTC) at-home diagnostic test that can distinguish and identify influenza A and B, sometimes referred to as the flu, and SARS-CoV-2, the virus that causes COVID-19, was granted an emergency use authorization (EUA) by the U.S. Food and Drug Administration. A single-use at-home test kit, the Lucira COVID-19 & Flu Home Test yields findings from self-collected nose swab samples in around half an hour. A single-use test for those exhibiting symptoms and indicators typical of a respiratory tract infection, including COVID-19, is the Lucira COVID-19 & Flu Home Test. The test is available without a prescription and may be done entirely at home with nose swab samples that people 14 years of age or older self-collect. Inventive Sparks, Expanding Markets Investing in major development strategies for influenza diagnostics manufacturers, investing rapidly and in multiplex test technologies, expanding at home and point-of-care test offerings, forming partnership with healthcare providers and governments, securing regulatory approval quickly and strengthening the global distribution network-in special emergence markets. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS

Things to do in UAE this weekend: From Labubu superfans to new summer brunches
Things to do in UAE this weekend: From Labubu superfans to new summer brunches

Khaleej Times

time14 hours ago

  • Entertainment
  • Khaleej Times

Things to do in UAE this weekend: From Labubu superfans to new summer brunches

Looking for a break from the routine? Whether you're craving a new thrill, a cool escape from the heat, or just something fun to shake up your weekend plans, here are the top things to do in the UAE right now: Labubu is here Get ready, Dubai! Loco Bear is teaming up with global sensation Labubu for an epic, first-of-its-kind Adventure Quest this Saturday, July 26 at their Al Quoz 2 space. From ninja runs to glow-in-the-dark laser tag, this immersive, multi-zone challenge blends physical play with collectible culture — and some seriously cool prizes. Whether you're a young adventure-seeker or Labubu superfan, this one's got all the makings of your most unforgettable Saturday yet. From 4pm to 7pm, limited spots available. Tuscany in Dubai Perfect for a summer brunch — think flowing linens, sun-dazed interiors, and that dolce far niente vibe — Il Borro Tuscan Bistro is a destination that seldom disappoints. Set within the elegant Jumeirah Al Naseem, this rustic-chic gem is filled with authentic Italian fare that transports you to the dreamy streets of Tuscany in no time. From heirloom recipes to ingredients flown in from the Ferragamo family estate, it's a slice of Italy right here in Dubai. Book ahead, as weekends tend to fill up fast: 04 275 2555. Pickl does breakfast now Smash burger king Pickl is now making our mornings better with its first-ever breakfast menu, available daily from 5am to 11am at its 24-hour locations in City Walk, JLT, and Motor City. Whether you're chasing a post-party bite or fuelling up before sunrise, Pickl's new breakfast may just hit the spot. Bonus: City Walk is serving up Southpour Coffee too. Available for dine-in, delivery, or a grab-and-go fix. New weekend brunch There's something about long, lazy Saturdays and good food that just works — and Farmers Commons at Hotel Local in Jumeirah Village Triangle has given us what we wanted. Their Farmers Market Brunch, held every Saturday from 1pm to 4pm, is all about fresh, feel-good flavours in a laid-back setting. Packages starting at Dh149; kids under 6 eat free, and there's 50 per cent off for 6–12-year-olds, making it a hit for families too. Adventure city Feeling adventurous this week? Then, skip the usual and 'dive' into something unforgettable. Head over to Deep Dive Dubai, home to the world's deepest pool and the UAE's most surreal scuba experience. And whether you're a first-timer or a seasoned diver, no license is needed. Guided by expert instructors in a cinematic, underwater world, you'll be gliding past submerged streets, floating cars, and hidden rooms you won't believe are real. Where: Nad Al Sheba, Meydan, Dubai.

HCA Healthcare (HCA) Reports Q2: Everything You Need To Know Ahead Of Earnings
HCA Healthcare (HCA) Reports Q2: Everything You Need To Know Ahead Of Earnings

Yahoo

timea day ago

  • Business
  • Yahoo

HCA Healthcare (HCA) Reports Q2: Everything You Need To Know Ahead Of Earnings

Hospital operator HCA Healthcare (NYSE:HCA) will be reporting earnings this Friday before the bell. Here's what to expect. HCA Healthcare beat analysts' revenue expectations by 0.5% last quarter, reporting revenues of $18.32 billion, up 5.7% year on year. It was a mixed quarter for the company, with an impressive beat of analysts' EPS estimates but a slight miss of analysts' same-store sales estimates. Is HCA Healthcare a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting HCA Healthcare's revenue to grow 5.6% year on year to $18.47 billion, slowing from the 10.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $6.32 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. HCA Healthcare has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 1.9% on average. Looking at HCA Healthcare's peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Tenet Healthcare delivered year-on-year revenue growth of 3.3%, beating analysts' expectations by 2.3%, and Quest reported revenues up 15.2%, topping estimates by 1.4%. Tenet Healthcare traded down 9.4% following the results while Quest was up 2.3%. Read our full analysis of Tenet Healthcare's results here and Quest's results here. Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices flat over the last month. HCA Healthcare is down 6% during the same time and is heading into earnings with an average analyst price target of $391.54 (compared to the current share price of $356.42). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Bargain Hunt star supported by fans as he makes huge announcement away from BBC show
Bargain Hunt star supported by fans as he makes huge announcement away from BBC show

Daily Mirror

time2 days ago

  • Entertainment
  • Daily Mirror

Bargain Hunt star supported by fans as he makes huge announcement away from BBC show

Bargain Hunt star Charles Hanson has announced his latest move away from the BBC show Bargain Hunt star Charles Hanson has been supported by fans as he made a huge announcement away from the BBC show. ‌ The beloved auctioneer is set to host a new auction show, giving viewers an exclusive peek into his Derbyshire salesroom and unveiling some "jaw-dropping discoveries". ‌ Charles took to Instagram on Tuesday (July 22) to tease fans with a promotional snapshot of his upcoming series, Secret Life of the Auction House, which will premiere on Quest on Thursday, July 31. ‌ His announcement post read: "Exciting news from Hansons Auctioneers! We're thrilled to announce our brand-new TV series, Secret Life of the Auction House! Step inside our Derbyshire saleroom as hundreds of thousands of extraordinary treasures pass through each year - from a 1966 World Cup flag to Queen Victoria's bloomers," reports the Express. "With exclusive, behind-the-scenes access, watch as Charles Hanson (@HansonsAuctions) and our 75-strong team research provenance, spot the fakes, and run the live auctions that send rare Harry Potter first editions, Victorian vampire slaying kits, and so much more out the door to eager collectors." ‌ The post also included details about the show's premiere: "Tune in Thursday 31st July at 9 PM on @QuestTV to catch the first episode!" Adding to the anticipation, the caption concluded: "Whether you're a seasoned collector or just love a good treasure hunt, this series is packed with insider tips, jawdropping discoveries, and all the auction excitement you could ask for." Charles received an outpouring of support from his fans in the comments section, with one writing: "I will look forward to this." ‌ Another added: "Sounds really interesting great to see behind the scenes," while a third expressed anticipation: "Fantastic. Looking forward to watching this." A fourth fan echoed the sentiment, saying: "Great news! I will be delighted to tune in!" ‌ In a recent update, Charles couldn't hide his excitement as he anticipated the launch of his new show. He took to X (formerly Twitter), saying: "Hope everyone's well this Tuesday (not Wednesday) evening! New show out soon! 31st July at 10pm (not 9pm) on #Quest #SecretLifeOfTheAuctionHouse." ‌ In a brief clip that was filmed in his car, Charles said: "I hope everyone is well. I'm really excited about a new show appearing on your TV screens. Making a show for Discovery Plus seen on Quest starting on the 31st July. "It's the Secret Life of the Auction House. It stars me and my brilliant team at Hansons Auctioneers as we cover all the country and we make some quite riveting, revealing, emotive, cliffhanging, nail-biting, times." He concluded: "We sell with theatre, drama and romance and we make a memory. So do tune in." Known for his appearances on Antiques Road Trip and Bargain Hunt, Charles is a familiar face to many. Bargain Hunt is available to stream on BBC iPlayer. Se cret Life of the Auction House premieres on July 31 at 10pm on Quest

The Ensign Group Earnings: What To Look For From ENSG
The Ensign Group Earnings: What To Look For From ENSG

Yahoo

time3 days ago

  • Business
  • Yahoo

The Ensign Group Earnings: What To Look For From ENSG

Healthcare services company The Ensign Group (NASDAQ:ENSG). will be reporting results this Thursday after the bell. Here's what investors should know. The Ensign Group met analysts' revenue expectations last quarter, reporting revenues of $1.17 billion, up 16.1% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts' sales volume estimates. Is The Ensign Group a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting The Ensign Group's revenue to grow 17.7% year on year to $1.22 billion, improving from the 12.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.55 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. The Ensign Group has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 0.6% on average. Looking at The Ensign Group's peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Tenet Healthcare delivered year-on-year revenue growth of 3.3%, beating analysts' expectations by 2.3%, and Quest reported revenues up 15.2%, topping estimates by 1.4%. Read our full analysis of Tenet Healthcare's results here and Quest's results here. Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices flat over the last month. The Ensign Group is down 8.7% during the same time and is heading into earnings with an average analyst price target of $166 (compared to the current share price of $138.93). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store